127 related articles for article (PubMed ID: 15549416)
1. Allelic differences in a quantitative trait locus affecting insulin-like growth factor-I impact skeletal acquisition and body composition.
Rosen CJ; Ackert-Bicknell C; Beamer WG; Nelson T; Adamo M; Cohen P; Bouxsein ML; Horowitz MC
Pediatr Nephrol; 2005 Mar; 20(3):255-60. PubMed ID: 15549416
[TBL] [Abstract][Full Text] [Related]
2. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
[TBL] [Abstract][Full Text] [Related]
3. Generation of a new congenic mouse strain to test the relationships among serum insulin-like growth factor I, bone mineral density, and skeletal morphology in vivo.
Bouxsein ML; Rosen CJ; Turner CH; Ackert CL; Shultz KL; Donahue LR; Churchill G; Adamo ML; Powell DR; Turner RT; Muller R; Beamer WG
J Bone Miner Res; 2002 Apr; 17(4):570-9. PubMed ID: 11918215
[TBL] [Abstract][Full Text] [Related]
4. Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition.
Delahunty KM; Shultz KL; Gronowicz GA; Koczon-Jaremko B; Adamo ML; Horton LG; Lorenzo J; Donahue LR; Ackert-Bicknell C; Kream BE; Beamer WG; Rosen CJ
Endocrinology; 2006 Aug; 147(8):3915-23. PubMed ID: 16675518
[TBL] [Abstract][Full Text] [Related]
5. Mapping quantitative trait loci for serum insulin-like growth factor-1 levels in mice.
Rosen CJ; Churchill GA; Donahue LR; Shultz KL; Burgess JK; Powell DR; Ackert C; Beamer WG
Bone; 2000 Oct; 27(4):521-8. PubMed ID: 11033447
[TBL] [Abstract][Full Text] [Related]
6. A chromosomal inversion within a quantitative trait locus has a major effect on adipogenesis and osteoblastogenesis.
Ackert-Bicknell CL; Salisbury JL; Horowitz M; DeMambro VE; Horton LG; Shultz KL; Lecka-Czernik B; Rosen CJ
Ann N Y Acad Sci; 2007 Nov; 1116():291-305. PubMed ID: 17584978
[TBL] [Abstract][Full Text] [Related]
7. Congenic strains of mice for verification and genetic decomposition of quantitative trait loci for femoral bone mineral density.
Shultz KL; Donahue LR; Bouxsein ML; Baylink DJ; Rosen CJ; Beamer WG
J Bone Miner Res; 2003 Feb; 18(2):175-85. PubMed ID: 12568393
[TBL] [Abstract][Full Text] [Related]
8. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone.
Yakar S; Bouxsein ML; Canalis E; Sun H; Glatt V; Gundberg C; Cohen P; Hwang D; Boisclair Y; Leroith D; Rosen CJ
J Endocrinol; 2006 May; 189(2):289-99. PubMed ID: 16648296
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.
Bikle DD; Sakata T; Leary C; Elalieh H; Ginzinger D; Rosen CJ; Beamer W; Majumdar S; Halloran BP
J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.
Pfeilschifter J; Laukhuf F; Müller-Beckmann B; Blum WF; Pfister T; Ziegler R
J Clin Invest; 1995 Aug; 96(2):767-74. PubMed ID: 7635970
[TBL] [Abstract][Full Text] [Related]
11. Genetic increase in serum insulin-like growth factor-I (IGF-I) in C3H/HeJ compared with C57BL/6J mice is associated with increased transcription from the IGF-I exon 2 promoter.
Adamo ML; Ma X; Ackert-Bicknell CL; Donahue LR; Beamer WG; Rosen CJ
Endocrinology; 2006 Jun; 147(6):2944-55. PubMed ID: 16527837
[TBL] [Abstract][Full Text] [Related]
12. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
[TBL] [Abstract][Full Text] [Related]
13. Energy-restricted diet benefits body composition but degrades bone integrity in middle-aged obese female rats.
Shen CL; Zhu W; Gao W; Wang S; Chen L; Chyu MC
Nutr Res; 2013 Aug; 33(8):668-76. PubMed ID: 23890357
[TBL] [Abstract][Full Text] [Related]
14. Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities.
Rosen CJ; Dimai HP; Vereault D; Donahue LR; Beamer WG; Farley J; Linkhart S; Linkhart T; Mohan S; Baylink DJ
Bone; 1997 Sep; 21(3):217-23. PubMed ID: 9276086
[TBL] [Abstract][Full Text] [Related]
15. Effects of liver-derived insulin-like growth factor I on bone metabolism in mice.
Sjögren K; Sheng M; Movérare S; Liu JL; Wallenius K; Törnell J; Isaksson O; Jansson JO; Mohan S; Ohlsson C
J Bone Miner Res; 2002 Nov; 17(11):1977-87. PubMed ID: 12412805
[TBL] [Abstract][Full Text] [Related]
16. Strain-specific effects of rosiglitazone on bone mass, body composition, and serum insulin-like growth factor-I.
Ackert-Bicknell CL; Shockley KR; Horton LG; Lecka-Czernik B; Churchill GA; Rosen CJ
Endocrinology; 2009 Mar; 150(3):1330-40. PubMed ID: 18948404
[TBL] [Abstract][Full Text] [Related]
17. PPARG by dietary fat interaction influences bone mass in mice and humans.
Ackert-Bicknell CL; Demissie S; Marín de Evsikova C; Hsu YH; DeMambro VE; Karasik D; Cupples LA; Ordovas JM; Tucker KL; Cho K; Canalis E; Paigen B; Churchill GA; Forejt J; Beamer WG; Ferrari S; Bouxsein ML; Kiel DP; Rosen CJ
J Bone Miner Res; 2008 Sep; 23(9):1398-408. PubMed ID: 18707223
[TBL] [Abstract][Full Text] [Related]
18. Mouse models for understanding the growth hormone insulin-like growth factor-I axis.
Rosen CJ
Horm Res; 2007; 68 Suppl 5():2-4. PubMed ID: 18174693
[TBL] [Abstract][Full Text] [Related]
19. Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism.
Yakar S; Rosen CJ; Bouxsein ML; Sun H; Mejia W; Kawashima Y; Wu Y; Emerton K; Williams V; Jepsen K; Schaffler MB; Majeska RJ; Gavrilova O; Gutierrez M; Hwang D; Pennisi P; Frystyk J; Boisclair Y; Pintar J; Jasper H; Domene H; Cohen P; Clemmons D; LeRoith D
FASEB J; 2009 Mar; 23(3):709-19. PubMed ID: 18952711
[TBL] [Abstract][Full Text] [Related]
20. Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion.
Govoni KE; Wergedal JE; Florin L; Angel P; Baylink DJ; Mohan S
Endocrinology; 2007 Dec; 148(12):5706-15. PubMed ID: 17717052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
